Skip to main content
. 2017 Jul 24;11:1179554917721710. doi: 10.1177/1179554917721710

Figure 2.

Figure 2.

Comparisons of the overall survival between the high-risk (HR) and standard-risk (SR) patients with B-ALL (70.3% for HR vs 90.4% for SR, P < .001). ALL indicates acute lymphoblastic leukemia.